Abstract: A data transmission circuit which is improved to be capable of supporting a data transmission mode appropriate for an interface or an application depending on the selection of an option. The data transmission circuit includes a pre-driver configured to output a first differential driving signal, a second differential driving signal and pre-emphasis control signals by using a first differential data signal, a second differential data signal and option signals; a main driver configured to output a first differential transmission signal and a second differential transmission signal by using the first differential driving signal and the second differential driving signal; and a pre-emphasis driver configured to perform pre-emphasis on the first differential transmission signal and the second differential transmission signal to different amplification degrees in a first mode and a second mode by the pre-emphasis control signals.

Abstract: A data transmission circuit which is improved to be capable of supporting a data transmission mode appropriate for an interface or an application depending on the selection of an option. The data transmission circuit includes a pre-driver configured to output a first differential driving signal, a second differential driving signal and pre-emphasis control signals by using a first differential data signal, a second differential data signal and option signals; a main driver configured to output a first differential transmission signal and a second differential transmission signal by using the first differential driving signal and the second differential driving signal; and a pre-emphasis driver configured to perform pre-emphasis on the first differential transmission signal and the second differential transmission signal to different amplification degrees in a first mode and a second mode by the pre-emphasis control signals.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter Syndrome.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter Syndrome.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: The present invention relates to a technique, a method, and a composition for controlling plant pathogens comprising a Bacillus amyloliquefaciens KBC1004 strain and a culture medium thereof as active ingredients. Particularly, the Bacillus amyloliquefaciens KBC1004 strain and the culture medium thereof of the present invention have excellent antifungal activity against various plant pathogens such as Rhizoctonia solani AG-2-2(IV) causing turfgrass diseases, Botrytis cinerea causing gray mold rot, Colletotrichum acutatum causing chili pepper anthracnose, Colletotrichum gleosprodes causing sweet persimmon anthracnose, Rhizoctonia cerealis causing yellow patch, Rhizoctonia solani AG-1(1A) causing brown patch, Sclerotium rolfsii causing southern blight, and Phytophthora drechsleri causing kiwifruit phytophthora blight, so that they can be efficiently used as an eco-friendly composition for controlling plant pathogens.

Abstract: A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Abstract: Disclosed are a sensor, a cooking apparatus having the sensor, and a control method of the cooking apparatus. The sensor serves to accurately sense a pollution level of the cooking apparatus and to inform of a cleaning time and/or cleaning method based on the pollution level. The pollution level of a cooking compartment may be objectively determined using the sensor that senses the pollution level via a variation of capacitance. Also, it may be possible to guide a cleaning time and/or cleaning method (e.g., manual cleaning, steam cleaning, thermal decomposition cleaning, etc.) based on the pollution level of the cooking compartment, allowing the cooking compartment to be cleaned in the cleaning method at an appropriate cleaning time. In particular, during a thermal decomposition cleaning operation, the pollution level is sensed in real time to enable variable control the cleaning time and automatic control of a cleaning ending time. This may contribute to reduce energy consumption and discharge of CO2.

Abstract: The present invention relates to a composition for preventing at least one plant disease resulted from infection of plant pathogens and a method for preparing the same. Particularly, the composition contains extract of at least one plant selected from the group consisting of Coptis chinensis Franch., Phellodendron genus plant, Sanguinaria canadensis and Chelidonium majus var. asiaticum which are natural plants having anti-plant pathogen activity or berberine which is purified therefrom. The composition of the present invention can be effectively used for preventing disease pathogens such as plant powdery mildew, anthracnose of pepper, damping-off of cucumber and gray mold rot of strawberry resulted from infection of plant pathogens such as Colletrotrichum gloeosporiodes, Pythium ultimum or Botrytis cinerea.

Abstract: A microwave oven includes a main body, a door opening and closing the main body, and a control panel placed in one side of the main body and provided with a plurality of function operators. A guide line is provided on the control panel and lights up to guide manipulation order of the function operator.

Abstract: A microwave oven includes a main body, a door opening and closing the main body, and a control panel placed in one side of the main body and provided with a plurality of function operators. A guide line is provided on the control panel and lights up to guide manipulation order of the function operator.

Abstract: Disclosed is a lyophilized preparation of recombinant factor VIII used as a therapeutic preparation of hemophilia A. The lyophilized preparation of recombinant factor VIII is prepared by performing lyophilization using a mixture comprising 6 to 100 mM of L-arginine, 3.5 to 50 mM of L-isoleucine, and 10 to 100 mM of L-glutamic acid as a stabilizer for stabilizing the recombinant factor VIII which exhibits an unstable activity during lyophilization, rather than using human blood derived albumin.